Reports Q2 revenue ales $3.80M , consensus $7.17M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EXAI:
- Exscientia initiated with a Buy at Berenberg
- Exscientia initiates prospective observational study in ovarian cancer
- Exscientia enrolls first patient in ELUCIDATE study
- GT Apeiron announces enrollment of first patient in Phase 1/2 ELUCIDATE study
- Exscientia expands tech leadership team, CTO Pairaudeau stepping down